🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The main purpose of this study is to determine the safety of LY2409021 in h...
Status
Completed
Location
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Start Date
2007-05
Trial ID
NCT01606371
Part A: The purpose of Part A of the study is to look at the electrocardiog...
Status
Completed
Location
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Start Date
2011-10
Trial ID
NCT01460368
Treatments Being Tested
This drug is being evaluated for possible treatment of type 2 diabetes mell...
Status
Completed
Location
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Start Date
2009-03
Trial ID
NCT00871572
This is a study to measure the effect that various doses of LY2409021 have ...
Status
Completed
Location
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Start Date
2007-11
Trial ID
NCT01606423
This is a study that involves multiple doses of study drug (60 mg of LY2409...
Status
Completed
Location
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST) or speak with your personal physician.
Start Date
2012-04
Trial ID
NCT01588366
The main purpose of the trial is to determine the effect of a study drug kn...
Status
Completed
Location
Advanced Clinical Research Institute
Start Date
2014-03
Trial ID
NCT02091362
This study involves taking a single dose of 100 milligrams (mg) or 300 mg L...
Status
Completed
Location
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Start Date
2012-07
Trial ID
NCT01640834
LY2409021 is being evaluated for possible treatment in type 2 diabetes. Thi...
Status
Completed
Location
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Start Date
2011-01
Trial ID
NCT01241448
Patients with diabetes are characterised not only by compromised insulin se...
Status
Unknown
Location
Multiple Locations
Start Date
2016-04
Trial ID
NCT02944110
Treatments Being Tested
In normal physiology, glucagon from pancreatic alpha cells plays an importa...
Status
Completed
Location
Center for Diabetes Research, Gentofte Hospital, Copenhagen University
Start Date
2016-05
Trial ID
NCT02792400